These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 17984578)

  • 1. [NF-kappaB as a therapeutic target of rheumatoid arthritis].
    Okamoto T; Tsuchiya A
    Nihon Rinsho Meneki Gakkai Kaishi; 2007 Oct; 30(5):383-9. PubMed ID: 17984578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The treatment of rheumatoid arthritis with NF-kappaB inhibitors].
    Jimi E; Nakamura I
    Nihon Rinsho; 2005 Sep; 63(9):1627-32. PubMed ID: 16164222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-canonical NF-κB signaling in rheumatoid arthritis: Dr Jekyll and Mr Hyde?
    Noort AR; Tak PP; Tas SW
    Arthritis Res Ther; 2015 Jan; 17(1):15. PubMed ID: 25774937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of nuclear factor-kappaB in the immune system and bone.
    Jimi E; Ghosh S
    Immunol Rev; 2005 Dec; 208():80-7. PubMed ID: 16313342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NF-kappaB and rheumatic diseases.
    Okamoto T
    Endocr Metab Immune Disord Drug Targets; 2006 Dec; 6(4):359-72. PubMed ID: 17214582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NF-kappaB as a potential therapeutic target in osteoarthritis and rheumatoid arthritis.
    Roman-Blas JA; Jimenez SA
    Osteoarthritis Cartilage; 2006 Sep; 14(9):839-48. PubMed ID: 16730463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NF-kappa B signaling and carcinogenesis.
    Okamoto T; Sanda T; Asamitsu K
    Curr Pharm Des; 2007; 13(5):447-62. PubMed ID: 17348842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small-molecule inhibitors of NF-kappaB for the treatment of inflammatory joint disease.
    Roshak AK; Callahan JF; Blake SM
    Curr Opin Pharmacol; 2002 Jun; 2(3):316-21. PubMed ID: 12020477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CYLD suppression enhances the pro-inflammatory effects and hyperproliferation of rheumatoid arthritis fibroblast-like synoviocytes by enhancing NF-κB activation.
    Zhang LM; Zhou JJ; Luo CL
    Arthritis Res Ther; 2018 Oct; 20(1):219. PubMed ID: 30285829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of NF-kappaB signaling by fasudil as a potential therapeutic strategy for rheumatoid arthritis.
    Okamoto H; Yoshio T; Kaneko H; Yamanaka H
    Arthritis Rheum; 2010 Jan; 62(1):82-92. PubMed ID: 20039418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-inflammatory drugs and tumor necrosis factor-alpha production from monocytes: role of transcription factor NF-kappa B and implication for rheumatoid arthritis therapy.
    Lavagno L; Gunella G; Bardelli C; Spina S; Fresu LG; Viano I; Brunelleschi S
    Eur J Pharmacol; 2004 Oct; 501(1-3):199-208. PubMed ID: 15464079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is NF-kappaB a useful therapeutic target in rheumatoid arthritis?
    Feldmann M; Andreakos E; Smith C; Bondeson J; Yoshimura S; Kiriakidis S; Monaco C; Gasparini C; Sacre S; Lundberg A; Paleolog E; Horwood NJ; Brennan FM; Foxwell BM
    Ann Rheum Dis; 2002 Nov; 61 Suppl 2(Suppl 2):ii13-8. PubMed ID: 12379614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the NF-kappaB pathway in the pathogenesis of human disease states.
    Yamamoto Y; Gaynor RB
    Curr Mol Med; 2001 Jul; 1(3):287-96. PubMed ID: 11899077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyphyllin I Ameliorates Collagen-Induced Arthritis by Suppressing the Inflammation Response in Macrophages Through the NF-κB Pathway.
    Wang Q; Zhou X; Zhao Y; Xiao J; Lu Y; Shi Q; Wang Y; Wang H; Liang Q
    Front Immunol; 2018; 9():2091. PubMed ID: 30319603
    [No Abstract]   [Full Text] [Related]  

  • 15. Intracellular signaling pathways as a target for the treatment of rheumatoid arthritis.
    Kumar S; Blake SM; Emery JG
    Curr Opin Pharmacol; 2001 Jun; 1(3):307-13. PubMed ID: 11712756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Negative regulation of NF-κB and its involvement in rheumatoid arthritis.
    van Loo G; Beyaert R
    Arthritis Res Ther; 2011 May; 13(3):221. PubMed ID: 21639951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The suppressive effects of Saposhnikovia divaricata (Fangfeng) chromone extract on rheumatoid arthritis via inhibition of nuclear factor-κB and mitogen activated proteinkinases activation on collagen-induced arthritis model.
    Kong X; Liu C; Zhang C; Zhao J; Wang J; Wan H; Zhu H; Zhang P; Chen W; Xiao Y; Lin N
    J Ethnopharmacol; 2013 Jul; 148(3):842-50. PubMed ID: 23711830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of nuclear factor-kappaB in the development of autoimmune diseases: a link between genes and environment.
    Kuryłowicz A; Nauman J
    Acta Biochim Pol; 2008; 55(4):629-47. PubMed ID: 19081854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NF-kappaB inhibitors for the treatment of inflammatory diseases and cancer.
    Calzado MA; Bacher S; Schmitz ML
    Curr Med Chem; 2007; 14(3):367-76. PubMed ID: 17305539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting IKKβ for the treatment of rheumatoid arthritis.
    Bamborough P; Morse MA; Ray KP
    Drug News Perspect; 2010 Oct; 23(8):483-90. PubMed ID: 21031164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.